-+ 0.00%
-+ 0.00%
-+ 0.00%

Radiopharm Theranostics Announces Phase 1 'HEAT' Trial Enrollment for RAD202 in Advanced HER2-Positive Solid Tumors

Reuters·07/29/2025 10:58:46

Please log in to view news